Lisanti Capital Growth LLC Boosts Stake in BrightSpring Health Services, Inc. (NASDAQ:BTSG)

Lisanti Capital Growth LLC increased its stake in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) by 4.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 331,910 shares of the company's stock after buying an additional 14,565 shares during the quarter. BrightSpring Health Services comprises approximately 1.4% of Lisanti Capital Growth LLC's investment portfolio, making the stock its 24th biggest holding. Lisanti Capital Growth LLC owned 0.19% of BrightSpring Health Services worth $5,652,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in BTSG. FMR LLC grew its stake in BrightSpring Health Services by 17.2% during the 3rd quarter. FMR LLC now owns 18,169,187 shares of the company's stock valued at $266,724,000 after purchasing an additional 2,664,582 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in BrightSpring Health Services in the fourth quarter valued at approximately $18,257,000. Walleye Capital LLC boosted its position in BrightSpring Health Services by 388.0% in the third quarter. Walleye Capital LLC now owns 167,112 shares of the company's stock valued at $2,453,000 after buying an additional 132,869 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in BrightSpring Health Services by 275.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 163,618 shares of the company's stock worth $2,402,000 after buying an additional 120,005 shares during the period. Finally, State Street Corp raised its position in BrightSpring Health Services by 7.4% during the 3rd quarter. State Street Corp now owns 1,239,628 shares of the company's stock worth $18,198,000 after buying an additional 85,464 shares during the last quarter.

Remove Ads

Analyst Upgrades and Downgrades

BTSG has been the topic of a number of research reports. UBS Group increased their price objective on shares of BrightSpring Health Services from $22.00 to $30.00 and gave the stock a "buy" rating in a research note on Wednesday, January 29th. CJS Securities started coverage on BrightSpring Health Services in a research note on Thursday, December 12th. They set an "outperform" rating and a $27.00 price objective for the company. Wells Fargo & Company boosted their price objective on BrightSpring Health Services from $17.00 to $21.00 and gave the company an "overweight" rating in a report on Wednesday, November 27th. Morgan Stanley raised their target price on BrightSpring Health Services from $19.00 to $20.00 and gave the stock an "overweight" rating in a report on Tuesday, December 17th. Finally, Bank of America boosted their price target on BrightSpring Health Services from $19.00 to $21.00 and gave the company a "buy" rating in a report on Wednesday, December 11th. One research analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $21.67.

BrightSpring Health Services Trading Up 4.7 %

BrightSpring Health Services stock traded up $0.76 during midday trading on Tuesday, hitting $16.79. 2,523,297 shares of the stock were exchanged, compared to its average volume of 1,626,691. The company has a current ratio of 1.35, a quick ratio of 0.97 and a debt-to-equity ratio of 1.63. The stock has a market capitalization of $2.94 billion, a price-to-earnings ratio of -64.58 and a beta of 2.21. The stock's 50-day simple moving average is $20.02 and its 200 day simple moving average is $17.59. BrightSpring Health Services, Inc. has a fifty-two week low of $7.85 and a fifty-two week high of $24.82.

BrightSpring Health Services Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.